FDA Solicits Protocol For Assessing Cosmetic Ingredient Aggregate Exposure Risks
According to its May 16 notice, the agency intends to award the contract to NSF International. An FDA spokesperson said NSF already undertook related work for the agency in 2018 and has rendered similar services for the US Environmental Protection Agency.
You may also be interested in...
US FDA’s Cosmetics Director Katz Cites Fragrance Allergens, Talc-Containing Products Among Priorities
Linda Katz, director of the US FDA’s Office of Cosmetics and Colors, offered insight into priority cosmetics issues at the Independent Beauty Association’s virtual FDA Cosmetic Regulations Workshop.
FDA sends warning letters to two Florida tattoo ink firms linked to a safety alert and recall in May and a New Jersey tattoo ink company for contamination in products that require the firms to quickly correct deficiencies that are a ‘significant’ health and regulatory concern.
The ingredients at issue already must be labeled on cosmetic products in the EU due to their recognized sensitization and allergy potential. FDA expects to award the contract by the end of September, and finished work will be due to the agency within 18 months thereafter.